LM_ID | Common Name | Systematic Name | Species Shorthand | Formula | Mass |
---|---|---|---|---|---|
LMST05050001 | Ptilosaponoside A | 3β-sulfoxy-4-β-(3'-sulfo-β-D- glucopyranosyloxy)-5α-pregn-20-en-19-ol | - | C27H44O14S2 | 656.2173 |
LMST05050002 | Ptilosaponoside B | 4-β-(3'-sulfo-β-D-glucopyranosyloxy)- 5α-pregn-20-en-3β,19-diol | - | C27H44O11S | 576.2604 |
LMST05050003 | Pandaroside A | 3β-[β-glucopyranosyl-(1-2)-β- glucopyranosyloxyuronic acid]-16- hydroxy-5α,14β-poriferast-16-ene-15, 23-dione | - | C41H64O15 | 796.4245 |
LMST05050004 | Pandaroside B | 3β-[β-glucopyranosyloxyuronic acid]- 16-hydroxy-5α,14β-poriferast-16-ene- 15,23-dione | - | C35H54O10 | 634.3717 |
LMST05050005 | Pandaroside C | 3β-[β-glucopyranosyl-(1-2)-β- glucopyranosyloxyuronic acid]-16- hydroxy-5α,14β-cholest-16-ene-15,23- dione | - | C39H60O15 | 768.3932 |
LMST05050006 | Pandaroside D | 3β-[β-glucopyranosyloxyuronic acid]- 16-hydroxy-5α,14β-cholest-16-ene-15, 23-dione | - | C33H50O10 | 606.3404 |
LMST05050007 | Ximaosteroid D | 3β-(2'-O-acetyl-α-fucopyranosyloxy)- pregna-5,20-diene | - | C29H44O6 | 488.3138 |
LMST05050008 | Evasterioside C | 3β-(β-D-xylopyranosyloxy)-6β,8β, 15α-trihydroxy-24-nor-cholest-22E-en- 26-yl sulfate | - | C31H52O12S | 648.3180 |
LMST05050009 | Evasterioside D | 24S-(β-D-glucopyranosyloxy)-5-α- cholestan-3β,6α,8,15β-tetrol | - | C33H58O10 | 614.4030 |
LMST05050010 | Evasterioside E | 3β,24S-di-(β-D-xylopyranosyloxy)-5-α- cholestan-6β,8,15α-triol | - | C37H64O13 | 716.4347 |
LMST05050011 | Asteriidoside L | 3β-(β-D-xylopyranosyloxy)-6β,8β, 15α-trihydroxy-campest-22E-en-28-yl sulfate | - | C33H56O12S | 676.3493 |
LMST05050012 | Evasterioside A | (25S)-3β-(β-D-xylopyranosyloxy)-6β, 8,15α-trihydroxy-5α-campest-22E-en-26- yl sulfate | - | C33H56O12S | 676.3493 |
LMST05050013 | Evasterioside B | 24-(β-D-xylopyranosyloxy)-6β,8,15α- trihydroxy-5α-cholest-22E-en-3-yl sulfate | - | C32H54O12S | 662.3336 |
LMST05050014 | Kurilensoside E | (25S)-3β-(2-O-methyl-β-D- xylopyranosyloxy)-5α-cholestan-4β,8, 15α,16β,26-pentol | - | C33H58O10 | 614.4030 |
LMST05050015 | Kurilensoside F | (25S)-3β-(2-O-methyl-β-D- xylopyranosyloxy)-cholestan-4β,5α,,8, 15α,16β,26-hexol | - | C33H58O11 | 630.3979 |
LMST05050016 | Kurilensoside G | (25S)-3β-(β-D-xylopyranosyloxy)- cholest-5-en-4β,5α,8,15α,16β,26- pentol | - | C32H54O10 | 598.3717 |
LMST05050017 | Kurilensoside H | (25S)-3β-(β-D-xylopyranosyloxy)-4β, 5β-epoxycholestan-6β,8,15α,16β,26- pentol | - | C32H54O11 | 614.3666 |
LMST05050018 | Echinasteroside C 15-O-sulfate | (25S)-3β-(2-O-methyl-β-D- xylopyranosyloxy)-6β,8,16β,26- tetrahydroxycholest-5-en-15α-yl sulfate | - | C33H56O13S | 692.3442 |
LMST05050019 | Kurilensoside I | 3β-(2-O-methyl-β-D-xylopyranosyloxy)- 24R-[2-O-methyl-β-D-xylopyranosyl-(1- 5)-α-L-arabinofuranosyloxy]-5α-cholest- 22E-en-4β,6α,7α,8,15β-pentol | - | C44H74O19 | 906.4824 |
LMST05050020 | Kurilensoside J | 3β-(2-O-3β-(2-O-methyl-β-D- xylopyranosyloxy)-24S-(α-L- arabinofuranosyloxy)-5α-cholestan-4β, 6β,15α-triol-β-D-xylopyranosyloxy)- 24R-[2-O-methyl-β-D-xylopyranosyl-(1- 5)-α-L-arabinofuranosyloxy]-5α-cholest- 22E-en-4β,6α,7α,8,15β-pentol | - | C37H64O14 | 732.4296 |
LMST05050021 | Anthenoside A | 16α-(4-O-methyl-2-acetamido-2-deoxy-β- D-glucopyranosyloxy)-5α-stigmast-8(14)- en-3α,6β,7β-triol | - | C38H65NO9 | 679.4659 |
LMST05050022 | Novaeguinoside A | 6α-(4-O-sulfonato-β-D- quinovopyranosyloxy)-5α-cholest-9(11)- en-3β,24-diyl disulfate | - | C33H56O16S3 | 804.2731 |
LMST05050023 | Novaeguinoside B | (25R)-6α-(4-O-sulfonato-β-D- quinovopyranosyloxy)-3β-sulfoxy-5α- campest-9(11),22E-dien-26-oyl taurine | - | C36H59NO17S3 | 873.2945 |
LMST05050024 | Squalamine (W) | 3β-N-1-(N-[3-(4-aminobutyl)]- 1,3- diaminopropane)-7α,24R-dihydroxy-5α- cholestane 24-sulfate | - | C34H65N3O5S | 627.4645 |
LMST05050025 | Dendrogenin A | 5α-hydroxy-6β-[2-(1H-imidazol-4-yl)- ethylamino]-cholestan-3β-ol | - | C32H55N3O2 | 513.4294 |
LMST05050027 | 16,23-epoxy-5β-cholestane triglycoside | (3β,5β,16β,22R,23S)-22-hydroxy-16, 23-epoxycholest-24-en-3-yl 6-deoxy-α-L- mannopyranosyl-(1->2)-β-D- glucopyranosyl-(1->2)-β-D- glucopyranoside | - | C45H74O17 | 886.4926 |
LMST05050028 | 17-β-estradiol glucuronide | 3-hydroxyestra-1,3,5(10)-trien-17β-yl β-D-glucopyranosiduronic acid | ST 18:3;O2;GlcA | C24H32O8 | 448.2097 |
LMST05050029 | Cholesteryl-α-D-glucoside | Cholest-5-en-3β-yl α-D-glucopyranoside | ST 27:1;O;Hex | C33H56O6 | 548.4077 |
LMST05050030 | 14:0-Glc-Cholesterol | Cholesteryl-6-O-tetradecanoyl-α-D- glucopyranoside | - | C47H82O7 | 758.6061 |
LMST05050031 | Cholesteryl-6-O-(dimyristoyl- glycerophospho)-α-D-glucoside | Cholesteryl-6-O-(1,2-ditetradecanoyl- sn-glycero-3-phospho)-α-D- glucopyranoside | - | C64H115O13P | 1122.8075 |
LMST05050032 | Hesperuside A | 7-O-(6-O-methyl-β-D-galactofuranosyl)- 16-O-(3-O-methyl-β-D-galactopyranosyl) -cholest-8(14),22E-dien-3α,6β,7β,16α- tetrol | - | C41H68O14 | 784.4609 |
LMST05050033 | Hesperuside B | 7-O-(6-O-methyl-β-D-galactofuranosyl)- 16-O-(3-O-methyl-β-D-galactopyranosyl) -cholest-8(14)-en-3α,6β,7β,16αtetrol | - | C41H70O14 | 786.4766 |
LMST05050034 | Hesperuside C | 7-O-(6-O-methyl-β-D-galactofuranosyl)- 16-O-(3-O-methyl-β-D-galactopyranosyl) -24-methylene-cholest-8(14)-en-3α,6β, 7β,16αtetrol | - | C42H70O14 | 798.4766 |
LMST05050035 | Microdiscusoside A | 25S-3-O-(β-D-xylopyranosyl)-26-O-(β- D-xylopyranosyl)-cholesta-4,24(28)- diene-3 β,6β,8,15α,16β,26-hexaol | - | C38H62O13 | 726.4190 |
LMST05050036 | Fuscaside B | (24S)-3,24-di-O-(β-D-xylopyranosyl)- 5α-cholestane-3β,6β,8,15α,24-pentol | - | C37H64O12 | 700.4398 |
LMST05050037 | - | (25S)-3-O-(2-O-methyl-β-D- xylopyranosyl)-26-O-(β-D- xylopyranosyl)-cholest-4-ene-3β,6β, 7α,8,15α,16β,26-heptaol | - | C38H64O15 | 760.4245 |
LMST05050038 | - | (25S)-3-O-(2-O-methyl-β-D- xylopyranosyl)-26-O-(β-D- xylopyranosyl)-cholest-4,24(28)-diene- 3β,6β,7α,8,15α,16β,26-heptaol | - | C39H64O15 | 772.4245 |
LMST05050039 | Linckoside I | (25S)-3-O-(2-O-methyl-β-D- xylopyranosyl)-26-O-(β-D- xylopyranosyl)-cholest-4,24(28)-diene- 3β,6β,8,15α,16β,26-hexaol | - | C39H64O14 | 756.4296 |
LMST05050040 | Linckoside F | (25S)-3-O-(2-O-methyl-β-D- xylopyranosyl)-cholest-4,24(28)-diene- 3β,6β,8,15α,16β,26-hexaol | - | C34H56O10 | 624.3873 |
LMST05050041 | Linckoside H | (25S)-3-O-(β-D-xylopyranosyl)-cholest- 4,24(28)-diene-3β,6β,8,15α,16β,26- hexaol | - | C33H54O10 | 610.3717 |
LMST05050042 | Linckoside G | (25S)-3-O-(β-D-xylopyranosyl)-cholest- 4,22E-diene-3β,6β,8,15α,16β,26- hexaol | - | C32H52O10 | 596.3560 |
LMST05050043 | Linckoside J | (25S)-3-O-(β-D-xylopyranosyl)-cholest- 4-ene-3β,6β,8,15α,16β,26-hexaol | - | C32H54O10 | 598.3717 |
LMST05050044 | Echinasteroside C | (25S)-3-O-(2-O-methyl-β-D- xylopyranosyl)-cholest-4-ene-3β,6β,8, 15α,16β,26-hexaol | - | C33H56O10 | 612.3873 |
LMST05050045 | Linckoside K | (24R)-3-O-(2-O-methyl-β-D- xylopyranosyl)-28-O-(α- arabinofuranosyl)-ergosta-4,22E-diene- 3β,6β,8,15α,16β,28-hexaol | - | C39H64O14 | 756.4296 |
LMST05050046 | Linckoside E | (24R)-3-O-(2-O-methyl-β-D- xylopyranosyl)-28-O-(α- arabinofuranosyl)-ergosta-4-ene-3β, 6β,8,15α,16β,28-hexaol | - | C39H66O14 | 758.4453 |
LMST05050047 | Linckoside A | (24R)-3-O-(2-O-methyl-β-D- xylopyranosyl)-29-O-(α- arabinofuranosyl)-stigmasta-4-ene-3β, 6β,8,15α,16β,28-hexaol | - | C40H68O14 | 772.4609 |
LMST05050048 | Linckoside B | 3-O-(2-O-methyl-β-D-xylopyranosyl)-29- O-(β-D-xylopyranosyl)-stigmasta-4-ene- 3β,6β,8,15α,16β,28-hexaol | - | C40H68O14 | 772.4609 |
LMST05050049 | Linckoside C | 3-O-(2-O-methyl-β-D-xylopyranosyl)-29- O-(β-D-xylopyranosyl)-28S-methyl- stigmasta-4-ene-3β,6β,8,15α,16β,28- hexaol | - | C41H70O14 | 786.4766 |
LMST05050050 | Linckoside D | 3-O-(2-O-methyl-β-D-xylopyranosyl)-29- O-(β-D-xylopyranosyl)-28S-methyl- stigmasta-4,22E-ene-3β,6β,8,15α,16β, 28-hexaol | - | C41H68O14 | 784.4609 |
LMST05050051 | SNAG-δ5-CA | 3β-sulfooxy-7β-N-acetylglucosaminyl- 5-cholen-24-oic acid | - | C32H51NO12S | 673.3132 |